Polycystic kidney disease: open trials in Belgium

4 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT04782258
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Trial Treatment · Phase 3 · Otsuka Pharmaceutical Development & Commercialization, Inc.
Universitair Ziekenhuis Gent, Gent · UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-23
NCT06902558
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Trial Treatment · Phase 2 · Calico Life Sciences LLC
UZ Leuven, Leuven · Centre Hospitalier Universitaire de Liège, Liège · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-10-06
NCT05373264
HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life
Trial Treatment · Phase 3 · University Medical Center Groningen
Universitair Ziekenhuis Antwerpen, Edegem · UZ Leuven, Leuven · Cliniques Universitaires Saint-Luc, Sint-Lambrechts-Woluwe
Registry updated 2026-08-25
NCT06970028
Somatosensory Phenotyping of ADPKD
Research · Universitaire Ziekenhuizen KU Leuven
UZ Leuven, Leuven
Registry updated 2025-11-17

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)